RT Book, Section
A1 Coil, Clinton J.
A1 Santen, Sally A.
A2 Tintinalli, Judith E.
A2 Ma, O. John
A2 Yealy, Donald M.
A2 Meckler, Garth D.
A2 Stapczynski, J. Stephan
A2 Cline, David M.
A2 Thomas, Stephen H.
SR Print(0)
ID 1206464422
T1 Transfusion Therapy
T2 Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260019933
LK accessemergencymedicine.mhmedical.com/content.aspx?aid=1206464422
RD 2024/04/24
AB Modern  transfusion  practice  uses  blood  collected  using  a  preservative–anticoagulant  combination  (usually  citrate  phosphate  dextrose  or  citrate  phosphate  dextrose  adenine-1).  The  collected  whole  blood  is  tested  for  transfusion-transmitted  diseases  and  most  often  separated  into  specific  components  supplied  as  standardized  preparations  termed  “units”  (Table  238-1).1  Transfusion  in  the  ED  typically  is  done  for  acute  blood  loss  and/or  circulatory  shock  using  packed  red  blood  cells  (PRBCs),  with  increasing  interest  in  using  stored  whole  blood  in  severely  bleeding  patients.2  Coagulation  factors  derived  from  human  plasma  or  manufactured  with  recombinant  technology  are  used  to  treat  hemorrhage  associated  with  a  deficiency  of  one  or  more  factors  or  to  reverse  the  effect  of  antithrombotic  medications  (see  Chapter  239,  “Thrombotics  and  Antithrombotics”)  (Table  238-2).